CYP2D6 and Alzheimer disease: In this study, 129 AD patients treated with DNP therapy were enrolled, and the researchers genotyped the relevant CYP2D6*3, CYP2D6*4, CYP2D6*5, and CYP2D6*6 alleles in patients.